In summary, the effect of combined administration of lycorine hydrochloride and anti-mouse CTLA-4 exhibited a potent therapeutic effect in the orthotopic and metastatic RCC tumor murine model and will serve as an excellent aid for developing a better treatment strategy for RCC. Here, CTLA4 is linked to neoplasm.